• TRAX share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • Price change

    The price of TRAX shares has increased $0.02 since the market last closed. This is a 0.05% rise.

  • Last closed at $41.87.

    The stock has since dropped $0.06 in pre-market trading.

Key terms

About TRAX

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

  • TRAX market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

Smart score

Latest TRAX news

Jul 28, 2026 10:05am ET Wedbush Remains a Buy on First Tracks Biotherapeutics Inc (TRAX) by TipRanks Jul 28, 2026 8:01am ET First Tracks Biotherapeutics price target raised to $60 from $30 at Wedbush by TipRanks Jul 28, 2026 6:15am ET First Tracks Biotherapeutics price target raised to $55 from $30 at Wells Fargo by TipRanks Jul 28, 2026 3:35am ET First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from Wells Fargo by TipRanks Jul 27, 2026 12:55pm ET First Tracks Biotherapeutics: Buy Rating Reaffirmed with Unchanged $44 Price Target on ANB033 CD122-Targeting Upside and Acquisition Potential by TipRanks Jul 27, 2026 12:05pm ET After Forte acquisition, H.C. Wainwright says First Tracks could be target by TipRanks Jul 21, 2026 6:20am ET First Tracks Biotherapeutics price target raised to $48 from $40 at Barclays by TipRanks Jul 21, 2026 5:01am ET Analysts Offer Insights on NA Companies: First Tracks Biotherapeutics Inc (TRAX) and Medacta Group SA (OtherMEDGF) by TipRanks Jul 20, 2026 7:27am ET Piper Sandler Remains a Buy on First Tracks Biotherapeutics Inc (TRAX) by TipRanks Jul 10, 2026 9:15am ET First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from UBS by TipRanks Jul 10, 2026 7:15am ET J.P. Morgan Remains a Buy on First Tracks Biotherapeutics Inc (TRAX) by TipRanks Jul 10, 2026 6:05am ET First Tracks Biotherapeutics price target raised to $44 from $30 at H.C. Wainwright by TipRanks Jul 10, 2026 5:55am ET Wells Fargo Reaffirms Their Buy Rating on First Tracks Biotherapeutics Inc (TRAX) by TipRanks Jul 10, 2026 4:11am ET Analysts Offer Insights on NA Companies: Fervo Energy Company Class A (FRVO) and First Tracks Biotherapeutics Inc (TRAX) by TipRanks Jul 08, 2026 9:25am ET Buy Rating on First Tracks (TRAX) Driven by Strengthening IL-15/CD122 Pathway Validation and Upcoming ANB033 Clinical Catalysts in Celiac Disease and Vitiligo by TipRanks Jun 08, 2026 5:00am ET First Tracks Biotherapeutics initiated with an Overweight at Wells Fargo by TipRanks May 23, 2026 8:27am ET J.P. Morgan Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX) by TipRanks May 15, 2026 10:20am ET Analysts’ Top Healthcare Picks: Monopar Therapeutics Inc (MNPR), First Tracks Biotherapeutics Inc (TRAX) by TipRanks May 15, 2026 6:26am ET Emily Bodnar Reiterates Buy on AnaptysBio, Keeps $30 Price Target on ANB033 Progress and Solid Cash Runway by TipRanks May 15, 2026 5:07am ET First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from Barclays by TipRanks May 11, 2026 11:26am ET Two new option listings and one option delisting on May 11th by TipRanks May 08, 2026 6:52pm ET First Tracks Biotherapeutics files to sell 10.5M shares of common for holders by TipRanks May 04, 2026 7:53am ET AnaptysBio price target lowered to $93 from $95 at Piper Sandler by TipRanks May 04, 2026 4:40am ET First Tracks Biotherapeutics initiated with an Overweight at Piper Sandler by TipRanks May 02, 2026 5:03am ET Analysts Are Bullish on Top Healthcare Stocks: Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD), First Tracks Biotherapeutics Inc (TRAX) by TipRanks

No recent press releases are available for TRAX

TRAX Financials

1-year income & revenue

  • TRAX total revenue: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • TRAX net income: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • TRAX earnings per share: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

Key terms

TRAX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

TRAX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

  • TRAX competitors: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • TRAX market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

Latest investing news